Elizabeth M. La

511 total citations
45 papers, 325 citations indexed

About

Elizabeth M. La is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Elizabeth M. La has authored 45 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 16 papers in Health and 10 papers in Infectious Diseases. Recurrent topics in Elizabeth M. La's work include Vaccine Coverage and Hesitancy (16 papers), Influenza Virus Research Studies (13 papers) and Respiratory viral infections research (13 papers). Elizabeth M. La is often cited by papers focused on Vaccine Coverage and Hesitancy (16 papers), Influenza Virus Research Studies (13 papers) and Respiratory viral infections research (13 papers). Elizabeth M. La collaborates with scholars based in United States, Belgium and United Kingdom. Elizabeth M. La's co-authors include Sandra E. Talbird, Sara Poston, Cosmina Hogea, Justin Carrico, Emmanuel Aris, Samantha K. Kurosky, Dawn Odom, Jessica K. DeMartino, Mawuli Nyaku and Craig S. Roberts and has published in prestigious journals such as PEDIATRICS, Diabetes and Vaccine.

In The Last Decade

Elizabeth M. La

42 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth M. La United States 10 219 141 66 42 25 45 325
Anja Saso United Kingdom 8 140 0.6× 82 0.6× 72 1.1× 36 0.9× 13 0.5× 14 341
Camilla Hiul Suppli Denmark 6 403 1.8× 134 1.0× 50 0.8× 86 2.0× 23 0.9× 9 499
Madeleine R. Valier United States 8 266 1.2× 228 1.6× 47 0.7× 43 1.0× 41 1.6× 9 387
Maria Giovanna Cappelli Italy 10 204 0.9× 156 1.1× 75 1.1× 47 1.1× 12 0.5× 18 349
Brooke Bregman United States 8 97 0.4× 64 0.5× 133 2.0× 69 1.6× 38 1.5× 10 337
Lynn Bahta United States 10 185 0.8× 199 1.4× 109 1.7× 19 0.5× 21 0.8× 13 357
Amit Srivastava United States 12 221 1.0× 152 1.1× 133 2.0× 119 2.8× 22 0.9× 40 390
Sara Barnett United Kingdom 7 122 0.6× 146 1.0× 64 1.0× 57 1.4× 17 0.7× 12 362
Chelsea S. Lutz United States 10 266 1.2× 211 1.5× 77 1.2× 32 0.8× 35 1.4× 17 388
W. William Schluter United States 13 195 0.9× 111 0.8× 164 2.5× 8 0.2× 38 1.5× 26 436

Countries citing papers authored by Elizabeth M. La

Since Specialization
Citations

This map shows the geographic impact of Elizabeth M. La's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth M. La with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth M. La more than expected).

Fields of papers citing papers by Elizabeth M. La

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth M. La. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth M. La. The network helps show where Elizabeth M. La may publish in the future.

Co-authorship network of co-authors of Elizabeth M. La

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth M. La. A scholar is included among the top collaborators of Elizabeth M. La based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth M. La. Elizabeth M. La is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Singer, David, Yan Wang, Aozhou Wu, et al.. (2025). RSV Testing Patterns and Characteristics Associated with RSV Testing Among Adults Aged 50 Years or Older in the United States. Infectious Diseases and Therapy. 14(10). 2321–2340.
3.
Singer, David, Yan Wang, Aozhou Wu, et al.. (2025). P-686. Risk of COPD Exacerbations, Asthma Exacerbations, and Hospitalizations for Heart Failure after RSV Hospitalization Among US Adults Aged at Least 50 Years. Open Forum Infectious Diseases. 12(Supplement_1). 2 indexed citations
4.
La, Elizabeth M., et al.. (2024). Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious Diseases and Therapy. 13(4). 827–844. 14 indexed citations
5.
La, Elizabeth M., James E. Graham, David Singer, et al.. (2024). Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States. Human Vaccines & Immunotherapeutics. 20(1). 2432745–2432745. 4 indexed citations
6.
La, Elizabeth M., et al.. (2024). Disparities in Respiratory Syncytial Virus Risk Factors, Diagnosis, and Outcomes in Adults by Race, Ethnicity, and Other Social Determinants of Health in the United States. Expert Review of Pharmacoeconomics & Outcomes Research. 25(4). 459–471. 4 indexed citations
7.
8.
La, Elizabeth M., Desmond Curran, Brandon J. Patterson, et al.. (2023). Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States. PharmacoEconomics - Open. 7(6). 975–985. 1 indexed citations
9.
Curran, Desmond, Brandon J. Patterson, Justin Carrico, et al.. (2023). Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human Vaccines & Immunotherapeutics. 19(1). 2167907–2167907. 9 indexed citations
10.
Curran, Desmond, et al.. (2022). Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States. Human Vaccines & Immunotherapeutics. 18(1). 2027196–2027196. 6 indexed citations
11.
La, Elizabeth M., et al.. (2021). National and State-Level Composite Completion of Recommended Vaccines Among Adolescents in the United States, 2015–2018. Journal of Adolescent Health. 69(5). 762–768. 3 indexed citations
12.
13.
La, Elizabeth M., et al.. (2021). Meningococcal B vaccination coverage among older adolescents in the United States. Vaccine. 39(19). 2660–2667. 12 indexed citations
14.
15.
Hunter, Shannon, et al.. (2021). State-Level Variations and Factors Associated with Adult Vaccination Coverage: A Multilevel Modeling Approach. PharmacoEconomics - Open. 5(3). 411–423. 6 indexed citations
16.
Brogan, Anita J., et al.. (2021). The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States. PharmacoEconomics. 39(4). 421–432. 3 indexed citations
17.
Carrico, Justin, Sandra E. Talbird, Elizabeth M. La, et al.. (2021). Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging population. Vaccine. 39(36). 5187–5197. 14 indexed citations
18.
Talbird, Sandra E., Elizabeth M. La, Justin Carrico, et al.. (2020). Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States. Human Vaccines & Immunotherapeutics. 17(2). 332–343. 37 indexed citations
19.
20.
Talbird, Sandra E., Elizabeth M. La, Justin Carrico, et al.. (2018). PIN25 - PROJECTED BURDEN OF VACCINE-PREVENTABLE DISEASES IN OLDER ADULTS IN THE UNITED STATES: IMPACT OF POPULATION AGING. Value in Health. 21. S225–S225. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anja Saso Breakdown of academic impact, for papers by Camilla Hiul Suppli Breakdown of academic impact, for papers by Madeleine R. Valier Breakdown of academic impact, for papers by Maria Giovanna Cappelli Breakdown of academic impact, for papers by Brooke Bregman Breakdown of academic impact, for papers by Lynn Bahta Breakdown of academic impact, for papers by Amit Srivastava Breakdown of academic impact, for papers by Sara Barnett Breakdown of academic impact, for papers by Chelsea S. Lutz Breakdown of academic impact, for papers by W. William Schluter
Rankless by CCL
2026